The 'Goldilocks' principle for curing brain cancer

by University of MinnesotaCancer cell during cell division. Credit: National Institutes of HealthIn the story of Goldilocks, a little girl tastes three different bowls of porridge to find which i

Updated on: April 10,2024

The 'Goldilocks' principle for curing brain cancer

by University of MinnesotaCancer cell during cell division. Credit: National Institutes of HealthIn the story of Goldilocks, a little girl tastes three different bowls of porridge to find which i

Updated on:April 10,2024

AI tool predicts risk of side effects after surgery and radiotherapy in breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA team of international researchers has developed an artificial intelligence (AI) tool that can predict wh

Updated on: March 30,2024

AI tool predicts risk of side effects after surgery and radiotherapy in breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA team of international researchers has developed an artificial intelligence (AI) tool that can predict wh

Updated on:March 30,2024

How deadly brain cancer evades treatments

by McMaster UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111420McMaster University researcher Sheila Singh and her team have discovered how glio

Updated on: February 03,2024

How deadly brain cancer evades treatments

by McMaster UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111420McMaster University researcher Sheila Singh and her team have discovered how glio

Updated on:February 03,2024

Researchers publish action plan to address appendiceal cancer enigmas

Updated on: April 29,2025

Researchers publish action plan to address appendiceal cancer enigmas

Updated on:April 29,2025

Increased adenoma detection rate may significantly reduce post-colonoscopy colorectal cancer risk

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study from the Italian Colorectal Cancer screening program including more than 49,000 colonoscopies found a significant

Updated on: January 07,2024

Increased adenoma detection rate may significantly reduce post-colonoscopy colorectal cancer risk

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study from the Italian Colorectal Cancer screening program including more than 49,000 colonoscopies found a significant

Updated on:January 07,2024

A new route to blocking children's bone cancer

by Weizmann Institute of ScienceThe lungs of an untreated mouse with Ewing sarcoma (left) contain numerous tumor cells (shown by luminescent colors) that have spread from the bone; the lungs of a

Updated on: March 27,2024

A new route to blocking children's bone cancer

by Weizmann Institute of ScienceThe lungs of an untreated mouse with Ewing sarcoma (left) contain numerous tumor cells (shown by luminescent colors) that have spread from the bone; the lungs of a

Updated on:March 27,2024

New strategy for treating the most aggressive type of brain cancer

by Maria Fernanda Ziegler,FAPESPCredit: CC0 Public DomainResearchers from the University of São Paulo (USP) in Brazil have developed a strategy for treating the most aggressive type of brain can

Updated on: April 09,2024

New strategy for treating the most aggressive type of brain cancer

by Maria Fernanda Ziegler,FAPESPCredit: CC0 Public DomainResearchers from the University of São Paulo (USP) in Brazil have developed a strategy for treating the most aggressive type of brain can

Updated on:April 09,2024

Markups for oncology services vary at the hospital level

(HealthDay)—There is significant variation in markup of outpatient oncology services across hospitals in the United States, according to a study published online Feb. 17 in theAmerican Journal o

Updated on: April 09,2024

Markups for oncology services vary at the hospital level

(HealthDay)—There is significant variation in markup of outpatient oncology services across hospitals in the United States, according to a study published online Feb. 17 in theAmerican Journal o

Updated on:April 09,2024

Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

by Impact Journals LLC(A) Axial T2 MR shows a heterogeneous mass in the cardiophrenic space with evidence of anterior chest wall invasion and intercostal invasion. (B) Axial T2 MR shows 35 % of reduct

Updated on: January 30,2024

Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

by Impact Journals LLC(A) Axial T2 MR shows a heterogeneous mass in the cardiophrenic space with evidence of anterior chest wall invasion and intercostal invasion. (B) Axial T2 MR shows 35 % of reduct

Updated on:January 30,2024

Metastatic cancers adapt their metabolism to the tissue in which they grow

by Ulrika Ernström,Chalmers University of TechnologyMetastatic tumors adapt their metabolism to the tissue in which they grow. The image shows a primary breast cancer tumour (pink) and the metas

Updated on: January 21,2024

Metastatic cancers adapt their metabolism to the tissue in which they grow

by Ulrika Ernström,Chalmers University of TechnologyMetastatic tumors adapt their metabolism to the tissue in which they grow. The image shows a primary breast cancer tumour (pink) and the metas

Updated on:January 21,2024

T cell behavior determines which tumors respond to treatment

by Weill Cornell Medical CollegeCredit: CC0 Public DomainImmunotherapy unleashes the power of the immune system to fight cancer. However, for some patients, immunotherapy doesn't work, and ne

Updated on: May 07,2024

T cell behavior determines which tumors respond to treatment

by Weill Cornell Medical CollegeCredit: CC0 Public DomainImmunotherapy unleashes the power of the immune system to fight cancer. However, for some patients, immunotherapy doesn't work, and ne

Updated on:May 07,2024

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on: March 30,2024

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on:March 30,2024